6-[3,5-dimethyl-1-(1-methyl-2,3-dihydrotetrazol-5-yl)pyrazol-4-yl]-2-[4-(1-methylpyrrolidin-3-yl)oxyanilino]-8-(4-methylsulfonylcyclohexyl)pyrido[2,3-d]pyrimidin-7-one;6-[2-fluoro-4-(3-methyl-2H-tetrazol-3-ium-5-yl)phenyl]-2-(4-piperidin-4-yloxyanilino)-8-[[2-(trifluoromethyl)phenyl]methyl]pyrido[2,3-d]pyrimidin-7-one;2-(3-fluoro-4-piperazin-1-ylanilino)-6-[4-methyl-2-(1,3-thiazol-2-yl)phenyl]-8-propan-2-ylpyrido[2,3-d]pyrimidin-7-one
C96H101F5N27O7S2+ — CID 162031011
Data last refreshed: (MolForge compound catalog, from PubChem)
About 6-[3,5-dimethyl-1-(1-methyl-2,3-dihydrotetrazol-5-yl)pyrazol-4-yl]-2-[4-(1-methylpyrrolidin-3-yl)oxyanilino]-8-(4-methylsulfonylcyclohexyl)pyrido[2,3-d]pyrimidin-7-one;6-[2-fluoro-4-(3-methyl-2H-tetrazol-3-ium-5-yl)phenyl]-2-(4-piperidin-4-yloxyanilino)-8-[[2-(trifluoromethyl)phenyl]methyl]pyrido[2,3-d]pyrimidin-7-one;2-(3-fluoro-4-piperazin-1-ylanilino)-6-[4-methyl-2-(1,3-thiazol-2-yl)phenyl]-8-propan-2-ylpyrido[2,3-d]pyrimidin-7-one
6-[3,5-dimethyl-1-(1-methyl-2,3-dihydrotetrazol-5-yl)pyrazol-4-yl]-2-[4-(1-methylpyrrolidin-3-yl)oxyanilino]-8-(4-methylsulfonylcyclohexyl)pyrido[2,3-d]pyrimidin-7-one;6-[2-fluoro-4-(3-methyl-2H-tetrazol-3-ium-5-yl)phenyl]-2-(4-piperidin-4-yloxyanilino)-8-[[2-(trifluoromethyl)phenyl]methyl]pyrido[2,3-d]pyrimidin-7-one;2-(3-fluoro-4-piperazin-1-ylanilino)-6-[4-methyl-2-(1,3-thiazol-2-yl)phenyl]-8-propan-2-ylpyrido[2,3-d]pyrimidin-7-one (PubChem CID 162031011) has the molecular formula C96H101F5N27O7S2+ and a molecular weight of 1904.17 g/mol. Its IUPAC name is 6-[3,5-dimethyl-1-(1-methyl-2,3-dihydrotetrazol-5-yl)pyrazol-4-yl]-2-[4-(1-methylpyrrolidin-3-yl)oxyanilino]-8-(4-methylsulfonylcyclohexyl)pyrido[2,3-d]pyrimidin-7-one;6-[2-fluoro-4-(3-methyl-2H-tetrazol-3-ium-5-yl)phenyl]-2-(4-piperidin-4-yloxyanilino)-8-[[2-(trifluoromethyl)phenyl]methyl]pyrido[2,3-d]pyrimidin-7-one;2-(3-fluoro-4-piperazin-1-ylanilino)-6-[4-methyl-2-(1,3-thiazol-2-yl)phenyl]-8-propan-2-ylpyrido[2,3-d]pyrimidin-7-one.
Molecular Properties
| Compound Name | 6-[3,5-dimethyl-1-(1-methyl-2,3-dihydrotetrazol-5-yl)pyrazol-4-yl]-2-[4-(1-methylpyrrolidin-3-yl)oxyanilino]-8-(4-methylsulfonylcyclohexyl)pyrido[2,3-d]pyrimidin-7-one;6-[2-fluoro-4-(3-methyl-2H-tetrazol-3-ium-5-yl)phenyl]-2-(4-piperidin-4-yloxyanilino)-8-[[2-(trifluoromethyl)phenyl]methyl]pyrido[2,3-d]pyrimidin-7-one;2-(3-fluoro-4-piperazin-1-ylanilino)-6-[4-methyl-2-(1,3-thiazol-2-yl)phenyl]-8-propan-2-ylpyrido[2,3-d]pyrimidin-7-one |
|---|---|
| PubChem CID | 162031011 |
| Molecular Formula | C96H101F5N27O7S2+ |
| Molecular Weight | 1904.17 g/mol |
| Exact Mass | 1902.77 |
| IUPAC Name | 6-[3,5-dimethyl-1-(1-methyl-2,3-dihydrotetrazol-5-yl)pyrazol-4-yl]-2-[4-(1-methylpyrrolidin-3-yl)oxyanilino]-8-(4-methylsulfonylcyclohexyl)pyrido[2,3-d]pyrimidin-7-one;6-[2-fluoro-4-(3-methyl-2H-tetrazol-3-ium-5-yl)phenyl]-2-(4-piperidin-4-yloxyanilino)-8-[[2-(trifluoromethyl)phenyl]methyl]pyrido[2,3-d]pyrimidin-7-one;2-(3-fluoro-4-piperazin-1-ylanilino)-6-[4-methyl-2-(1,3-thiazol-2-yl)phenyl]-8-propan-2-ylpyrido[2,3-d]pyrimidin-7-one |
| SMILES | C[n+]1nc(-c2ccc(-c3cc4cnc(Nc5ccc(OC6CCNCC6)cc5)nc4n(Cc4ccccc4C(F)(F)F)c3=O)c(F)c2)n[nH]1.Cc1ccc(-c2cc3cnc(Nc4ccc(N5CCNCC5)c(F)c4)nc3n(C(C)C)c2=O)c(-c2nccs2)c1.Cc1nn(C2=NNNN2C)c(C)c1-c1cc2cnc(Nc3ccc(OC4CCN(C)C4)cc3)nc2n(C2CCC(S(C)(=O)=O)CC2)c1=O |
| InChI | InChI=1S/C34H29F4N9O2.C32H41N11O4S.C30H30FN7OS/c1-46-44-30(43-45-46)20-6-11-26(29(35)17-20)27-16-22-18-40-33(41-23-7-9-24(10-8-23)49-25-12-14-39-15-13-25)42-31(22)47(32(27)48)19-21-4-2-3-5-28(21)34(36,37)38;1-19-28(20(2)43(37-19)32-36-38-39-41(32)4)27-16-21-17-33-31(34-22-6-10-24(11-7-22)47-25-14-15-40(3)18-25)35-29(21)42(30(27)44)23-8-12-26(13-9-23)48(5,45)46;1-18(2)38-27-20(15-24(29(38)39)22-6-4-19(3)14-23(22)28-33-10-13-40-28)17-34-30(36-27)35-21-5-7-26(25(31)16-21)37-11-8-32-9-12-37/h2-11,16-18,25,39H,12-15,19H2,1H3,(H,40,41,42,44,48);6-7,10-11,16-17,23,25-26,38-39H,8-9,12-15,18H2,1-5H3,(H,33,34,35);4-7,10,13-18,32H,8-9,11-12H2,1-3H3,(H,34,35,36)/p+1 |
| InChIKey | QMXZSMVKOITXTN-UHFFFAOYSA-O |
| XLogP | 13.61 |
| TPSA | 378.39 Ų |
| H-Bond Donors | 8 |
| H-Bond Acceptors | 33 |
| Rotatable Bonds | 21 |
| Heavy Atoms | 137 |
| Complexity | — |
Lipinski Rule of Five
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1904.17 |
| LogP ≤ 5 | 13.61 |
| H-Bond Donors ≤ 5 | 8 |
| H-Bond Acceptors ≤ 10 | 33 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'anil_di_alk_A(478)', 'substructure': 'N/A'}, {'alert_name': 'quaternary_nitrogen_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 162031011 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.